Diabeloop today announced the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from Sooil in ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit.

The Indianapolis campus produces approximately 5.2 billion Accu-Chek diabetes test strips annually and serves as a major distribution hub for the U.S. market and 53 other countries.

The Indianapolis site currently serves as one of two global distribution hubs for Accu-Chek diabetes test strips. The site also houses the company’s U.S. research and development, along with ...

Right now, it produces approximately 5.2 billion Accu-Chek diabetes test strips annually. Roche says it plans to invest $50 billion in pharmaceuticals and diagnostics in the United States over the ...

Roche Diagnostics will build a $550 million expansion to produce continuous glucose monitors at an Indianapolis facility. Roche will use the site to make its Accu-Chek Smartguide devices, which ...

It currently produces approximately 5.2 billion Accu-Chek ® diabetes test strips annually and serves as one of two global distribution hubs focused on serving the U.S. market and supporting ...

Roche already has a significant presence in Indianapolis. The city serves as the North American headquarters for Roche Diagnostics under the Roche Group, the world’s largest biotech company. Roche’s ...

As the global burden of diabetes continues to grow, the healthcare industry is undergoing a quiet revolution in how insulin is delivered. By 2025, the disposable insulin-delivery device market is ...

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding several hundred jobs.

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit. The Swiss pharmaceutical and diagnostics giant ...